药审-话题@MedSci - 梅斯（MedSci）

#药审#

39篇内容 | 1621人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则（试行）》, objectType=article, longId=210032, objectId=a86f2100326d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a86f2100326d, replyNumber=0, likeNumber=89, createdTime=2021-08-04, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a86f2100326d, moduleTitle=国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则（试行）》, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a86f2100326d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707898, encodeId=30be1e07898ea, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=不受制NMPA加速创新审评，药审、械审大湾区分中心挂牌成立, objectType=article, longId=205618, objectId=7b9e2056187f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b9e2056187f, replyNumber=0, likeNumber=91, createdTime=2021-02-15, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b9e2056187f, moduleTitle=不受制NMPA加速创新审评，药审、械审大湾区分中心挂牌成立, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7b9e2056187f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707897, encodeId=e98d1e07897c8, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=这个药审批通过，事关中国2.9亿不良心血管事件患者, objectType=article, longId=186049, objectId=3b6a1860490d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b6a1860490d, replyNumber=0, likeNumber=80, createdTime=2020-12-10, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b6a1860490d, moduleTitle=这个药审批通过，事关中国2.9亿不良心血管事件患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3b6a1860490d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707896, encodeId=85ea1e078965d, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=药审中心拟优先审评名单更新, objectType=article, longId=164813, objectId=f051164813a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f051164813a9, replyNumber=0, likeNumber=92, createdTime=2020-01-21, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f051164813a9, moduleTitle=药审中心拟优先审评名单更新, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f051164813a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707891, encodeId=f28a1e07891fe, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=医改40年巡礼：药审改革为患者用上新药好药持续发力, objectType=article, longId=154810, objectId=c3c915481059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c915481059, replyNumber=0, likeNumber=81, createdTime=2019-10-08, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c915481059, moduleTitle=医改40年巡礼：药审改革为患者用上新药好药持续发力, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c3c915481059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707892, encodeId=fe811e07892b9, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=FDA依然深陷“停摆期”，新药审评工作暂停, objectType=article, longId=158042, objectId=b9b91580423a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9b91580423a, replyNumber=0, likeNumber=90, createdTime=2019-08-20, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9b91580423a, moduleTitle=FDA依然深陷“停摆期”，新药审评工作暂停, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b9b91580423a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707888, encodeId=4c361e0788851, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=新药审批加速中国患者有望比欧美更早获得新药, objectType=article, longId=146197, objectId=f01914619e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f01914619e5d, replyNumber=0, likeNumber=92, createdTime=2019-06-13, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f01914619e5d, moduleTitle=新药审批加速中国患者有望比欧美更早获得新药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f01914619e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707893, encodeId=38701e07893b9, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=境外抗癌新药审批提速促境内同步上市, objectType=article, longId=159946, objectId=b3e515994690, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3e515994690, replyNumber=0, likeNumber=90, createdTime=2019-11-13, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3e515994690, moduleTitle=境外抗癌新药审批提速促境内同步上市, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b3e515994690)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707895, encodeId=8d771e078955e, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=国家药监部门走访全国政协委员共话药审改革, objectType=article, longId=162449, objectId=d58a16244921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d58a16244921, replyNumber=0, likeNumber=85, createdTime=2020-01-16, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d58a16244921, moduleTitle=国家药监部门走访全国政协委员共话药审改革, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d58a16244921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707894, encodeId=f0481e0789422, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=46位全国政协委员联名提案：积极发挥药审专家咨询委作用, objectType=article, longId=161785, objectId=d57f161e8546, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d57f161e8546, replyNumber=0, likeNumber=75, createdTime=2019-05-17, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d57f161e8546, moduleTitle=46位全国政协委员联名提案：积极发挥药审专家咨询委作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d57f161e8546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707882, encodeId=c02c1e078821d, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=CIT 2018：FDA新药审批顾问：抗血小板治疗的传说与现实, objectType=article, longId=134386, objectId=af41134386ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af41134386ae, replyNumber=0, likeNumber=74, createdTime=2018-04-24, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af41134386ae, moduleTitle=CIT 2018：FDA新药审批顾问：抗血小板治疗的传说与现实, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=af41134386ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707890, encodeId=15521e07890fd, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=“求药神，不如求药审”：中国“新药把关人”的三年进击, objectType=article, longId=153643, objectId=e14a15364394, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e14a15364394, replyNumber=0, likeNumber=80, createdTime=2019-03-23, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e14a15364394, moduleTitle=“求药神，不如求药审”：中国“新药把关人”的三年进击, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e14a15364394)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707889, encodeId=28031e0788991, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=靴子落地 “默许制”加速新药审批, objectType=article, longId=153003, objectId=778015300337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=778015300337, replyNumber=0, likeNumber=92, createdTime=2019-01-25, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=778015300337, moduleTitle=靴子落地 “默许制”加速新药审批, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=778015300337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707887, encodeId=5c9d1e07887c3, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=Science：用数据揭露，美国FDA新药审核员与药企之间不得不说的“暧昧”, objectType=article, longId=144255, objectId=1e061442554c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e061442554c, replyNumber=0, likeNumber=74, createdTime=2019-01-03, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e061442554c, moduleTitle=Science：用数据揭露，美国FDA新药审核员与药企之间不得不说的“暧昧”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1e061442554c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707881, encodeId=d53a1e07881c3, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=国产14价宫颈癌疫苗拟纳入优先审评，药审中心：上市尚早, objectType=article, longId=134007, objectId=aff413400edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aff413400edb, replyNumber=0, likeNumber=81, createdTime=2019-02-18, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aff413400edb, moduleTitle=国产14价宫颈癌疫苗拟纳入优先审评，药审中心：上市尚早, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aff413400edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707883, encodeId=ea671e078836d, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=李进教授：药审新政下中国抗肿瘤新药临床研究的机遇, objectType=article, longId=136203, objectId=92801362038b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92801362038b, replyNumber=0, likeNumber=89, createdTime=2019-01-02, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92801362038b, moduleTitle=李进教授：药审新政下中国抗肿瘤新药临床研究的机遇, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=92801362038b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707879, encodeId=87db1e0787907, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=“中药审批免临床试验”系误读, objectType=article, longId=124415, objectId=c2141244158e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2141244158e, replyNumber=0, likeNumber=73, createdTime=2018-08-18, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2141244158e, moduleTitle=“中药审批免临床试验”系误读, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c2141244158e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707885, encodeId=ed7e1e078858f, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=加快境外上市新药审评审批获积极进展, objectType=article, longId=141598, objectId=cf8214159850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf8214159850, replyNumber=0, likeNumber=88, createdTime=2018-07-29, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf8214159850, moduleTitle=加快境外上市新药审评审批获积极进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cf8214159850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707884, encodeId=fda21e078843e, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=焦点访谈聚焦药品审评新药审批进入快车道, objectType=article, longId=137506, objectId=f7a913e506e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a913e506e4, replyNumber=0, likeNumber=89, createdTime=2018-08-20, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a913e506e4, moduleTitle=焦点访谈聚焦药品审评新药审批进入快车道, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f7a913e506e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707886, encodeId=c8c91e078861a, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, objectTitle=NEJM：无转移生存可以作为前列腺癌新药审批的主要终点(SPARTAN研究), objectType=article, longId=142293, objectId=9492142293cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9492142293cf, replyNumber=0, likeNumber=77, createdTime=2018-09-03, rootId=0, userName=h.y200607_23674428, userId=e54731497337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9492142293cf, moduleTitle=NEJM：无转移生存可以作为前列腺癌新药审批的主要终点(SPARTAN研究), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9492142293cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药审

2020-05-29

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则（试行）》

2021-08-04

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

不受制NMPA加速创新审评，药审、械审大湾区分中心挂牌成立

2021-02-15

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

这个药审批通过，事关中国2.9亿不良心血管事件患者

2020-12-10

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

药审中心拟优先审评名单更新

2020-01-21

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

医改40年巡礼：药审改革为患者用上新药好药持续发力

2019-10-08

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

FDA依然深陷“停摆期”，新药审评工作暂停

2019-08-20

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

新药审批加速中国患者有望比欧美更早获得新药

2019-06-13

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

境外抗癌新药审批提速促境内同步上市

2019-11-13

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

国家药监部门走访全国政协委员共话药审改革

2020-01-16

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

46位全国政协委员联名提案：积极发挥药审专家咨询委作用

2019-05-17

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

CIT 2018：FDA新药审批顾问：抗血小板治疗的传说与现实

2018-04-24

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

“求药神，不如求药审”：中国“新药把关人”的三年进击

2019-03-23

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

靴子落地 “默许制”加速新药审批

2019-01-25

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

Science：用数据揭露，美国FDA新药审核员与药企之间不得不说的“暧昧”

2019-01-03

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

国产14价宫颈癌疫苗拟纳入优先审评，药审中心：上市尚早

2019-02-18

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

李进教授：药审新政下中国抗肿瘤新药临床研究的机遇

2019-01-02

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

“中药审批免临床试验”系误读

2018-08-18

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

加快境外上市新药审评审批获积极进展

2018-07-29

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

焦点访谈聚焦药品审评新药审批进入快车道

2018-08-20

h.y200607_23674428 (审核中...)

前往app查看评论内容

#药审#

NEJM：无转移生存可以作为前列腺癌新药审批的主要终点(SPARTAN研究)

2018-09-03

科室
- - 订阅+
  - 更多科室
工具
服务